Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
Ampronix
GLOBETECH PUBLISHING LLC

Retinal Imaging Detects Changes Associated with Alzheimer's Disease

By Medimaging International staff writers
Posted on 23 Jul 2014
Image: Amyloid plaques showing up in retinal scan as fluorescent spots as curcumin binds to them (Photo courtesy of CSIRO).
Image: Amyloid plaques showing up in retinal scan as fluorescent spots as curcumin binds to them (Photo courtesy of CSIRO).
A noninvasive optical imaging device can provide early detection of changes that later occur in the brain and are a classic sign of Alzheimer's disease (AD), according to a new study.

Researchers at the Commonwealth Scientific and Industrial Research Organization (CSIRO, Melbourne, Australia) conducted a study to measure retinal beta-amyloid plaque in 40 volunteers, using a fluorescence-based scan that was compared to the results of brain positron emission tomography (PET) scans using the Pittsburgh Compound B (PiB) amyloid tracer. The researchers used orally administered curcumin as a tracer, on the basis of previous research indicating that it binds beta-amyloid protein with high affinity.

The researchers found that besides correlating strongly with plaque burden estimates from PiB-based PET scans, the retinal scans distinguished patients with AD from other participants with 100% sensitivity and a specificity of 80.6%. For the study, the researchers used the NeuroVision system, a product of NeuroVision Imaging (Sacramento, CA, USA), which provides a count of beta-amyloid plaques in the retina, their two-dimensional (2D) extent in square microns, and their distribution. All three parameters are combined into a "retinal amyloid index" to provide a single-number estimate of beta-amyloid plaque burden.

The Australian study is one of several in progress to determine if similar results can be confirmed in humans living with the disease. The study involves a total of 220 patients composed of diagnosed with AD, including a group with mild cognitive impairment, another group of people with no evidence of brain abnormality, and controls. The study was presented at the Alzheimer's Association International Conference, held during July 2014 in Copenhagen (Denmark).

“All people with the disease tested positive and most of the people without the disease tested negative,” said lead author and study presenter Shaun Frost, MSc, BSc, a biomedical scientist at CSIRO. “The optical imaging exam appears to detect changes that occur 15–20 years before clinical diagnosis. It's a practical exam that could allow testing of new therapies at an earlier stage, increasing our chances of altering the course of Alzheimer's disease.”

“PET scans require the use of radioactive tracers, and cerebrospinal fluid analysis requires that patients undergo invasive and often painful lumbar punctures,” said Prof. Keith Black, MD, chair of the department of neurosurgery at Cedars-Sinai Hospital (Los Angeles, CA, USA), who helped develop the NeuroVision system. “The retina, unlike other structures of the eye, is part of the central nervous system, sharing many characteristics of the brain. By staining the plaque with curcumin […] we could detect it in the retina even before it began to accumulate in the brain.”

Curcumin, a major component of the yellow Indian spice turmeric, has fluorescent properties, and is also believed to have a variety of medicinal qualities.

Related Links:
Commonwealth Scientific and Industrial Research Organization
NeuroVision Imaging



Channels

Radiography

view channel
Image: 3-D Model of the Heart (Photo courtesy of Materialise).

3-D Human Heart Printed Using Imaging Techniques

Congenital heart specialists have printed a 3-D anatomic model of a patient’s heart by integrating CT and Echocardiography techniques. This is the first time that researchers have integrated Computed... Read more

Ultrasound

view channel
Image: The Lumify, app-based ultrasound system (Photo courtesy of Philips).

Philips Debuts First App-Based Ultrasound

An app-based ultrasound solution aims extending the reach of ultrasound applications using mobile technology. The app was presented at the Social Media and Critical Care conference, June, 23–26, 2015... Read more

Nuclear medicine

view channel

Hybrid Scanner Using Five Molecular Imaging Techniques Under Development

Scientists are developing a new molecular, preclinical hybrid imaging system to help find new drugs and to advance imaging research. The scanner was presented at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI; Reston, Virginia, USA), and consists of a window for tissue observation,... Read more

General/Advanced Imaging

view channel

FDA Approves Trial for Intraoperative Image-Guided Cancer Surgery System

The US Food and Drug Administration (FDA) has provided Investigational Device Exemption (IDE) approval for company to trial a new image-guided cancer surgery system for intraoperative imaging of breast cancer. The surgical system consists of a cancer-specific molecular imaging agent, and a lightweight hand-held single-cell... Read more

Imaging IT

view channel
Image: Siemens radiation therapy Syngo.via image suite (Photo courtesy of Siemens Healthcare).

New Version of Syngo.via Supports Treatment Decision in Oncology

Siemens Healthcare has released a new version of oncology diagnostics software that helps physicians plan the best course of treatment for cancer patients. Cancer treatment requires comprehensive diagnostics,... Read more

Industry News

view channel

Konica Minolta Acquires Brazilian X-Ray Equipment Manufacturer

Konica Minolta Healthcare (Tokyo, Japan) has acquired a Brazilian digital X-Ray equipment manufacturer in Brazil to strengthen its presence in that country. The acquisition enables Konica Minolta to market its own Digital Radiography (DR), and Computed Radiography (CR) product lines in Brazil, which has a population... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.